The $8 - $10 targets are based on a very conservative value of Firdapse alone within the next few quarters and do not cover the potential of CPP-115 nor the future value of Firdapse as it expands to other indications. CPP-115 is still in early stages and therefore not included in setting the price target. CPP-115 has Hugh potential! I shall wait patiently and continue to use conservative values until more data is available.
Especially noteworthy: Silverman delivered another lecture in February of this year entitled "CPP-115: A Novel GABA Aminotransferase Inactivator and Potential New Treatment for Whatever Ails You" He has a lot of ego to make such a statement but remember that he is also one of the most successful drug inventors. It should be an interesting and IMO very profitable next few quarters and possibly even years of profit. GL!
Thank you for your post, the following is information alraedy posted but worth repeating IMO
Institutional Ownership: from 47.54% Q1 to at least 52.81% Q2
New Positions 36 (2,289,774 shares)
Sold Out Positions 13 (659,830 shares)
Point 72 still owns 3.46 million shares.
I've held since $1.38 and look forward to the slow but continued growth through 2016 - 2017. I hope to be at $8 - $10 within the next few quarters. GLTA!